Michael Hsieh
Pediatric Urology · Washington, DCNPI 1053552109
Payments from drug & device makers
What this record shows
This record is dominated by other: $942,963 of the $944,162 with a category attached, or 99.9%. Stryker accounts for 99.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $943,142 and has fallen 100.0% since, to $189 in 2024.
Across 23 payments — averaging $41,051 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$943K
- Boston Scientific$922
- Neotract Inc.$137
- Dendreon Pharmaceuticals LLC$35
- Olympus America Inc.$30
- Exelixis Inc.$17
What the payments were for
- Food & beverage$1,1990%
- Other$942,963100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 3 | $943,021 |
| Boston Scientific | 15 | $922 |
| Neotract Inc. | 1 | $137 |
| Dendreon Pharmaceuticals LLC | 1 | $35 |
| Olympus America Inc. | 2 | $30 |
| Exelixis Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$137
- AMS AMBICOR$128
- AMS 700 CXR RTE KIT$119
- AMBICOR$108
- Advantage System$108
How this compares
Too few pediatric urology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Other pediatric urology in Washington
- Christopher StaniorskiWashington$2K
- Hans PohlWashington$62
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.